terconazole

FDA Drug Profile — Terconazole, Terconazole Vaginal Cream 0.8%

terconazole is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Terconazole, Terconazole Vaginal Cream 0.8%. Available dosage form: cream.

Drug details

Generic Name
terconazole
Brand Names
Terconazole, Terconazole Vaginal Cream 0.8%
Application Number
ANDA076712
Sponsor
E. Fougera & Co. A Division Of Fougera Pharmaceuticals, LLC
NDC Codes
4
Dosage Forms
CREAM
Routes
VAGINAL
Active Ingredients
TERCONAZOLE

Indications and Usage

INDICATIONS AND USAGE Terconazole Vaginal Suppositories, 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As this product is effective only for vulvovaginitis caused by the genus Candida, the diagnosis should be confirmed by KOH smears and/or cultures.

Warnings

WARNINGS Anaphylaxis and toxic epidermal necrolysis have been reported during terconazole therapy. Terconazole Vaginal Suppositories, 80 mg therapy should be discontinued if anaphylaxis or toxic epidermal necrolysis develops.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.